“EVO ICL is the next logical step in refractive innovation. While adoption of any new technology takes time, EVO ICL’s adoption rate has been steadily rising since launch – achieving market leadership ...

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, ...

Lehi, Utah - January 14, 2026 - PRESSADVANTAGE - Waite Vision has announced the publication of a new article titled Dr.

Modern Vision Centers has released a new article titled “The Truth About EVO ICL and Glare: What Research Actually Shows,” addressing one of the most common questions patients have about implantable ...